Oklo Stock Jumped Today: Should You Buy Before Earnings?

oklo stock jumped after two major regulatory and program milestones on Tuesday, and the company will release its quarterly and full-year results after market close on March 17 at 5: 00 p. m. ET. The moves — a U. S. Department of Energy safety design agreement for Oklo’s first reactor at Idaho National Laboratory and a Nuclear Regulatory Commission materials license for Oklo’s Atomic Alchemy isotope unit — pushed trading higher in early hours and kept attention on the company through the afternoon. Investors watched the stock reaction closely as management heads into the earnings call.
Oklo Stock Rally Tied to DOE and NRC Milestones
Oklo secured two distinct advances that accelerated execution: the Department of Energy approved a Nuclear Safety Design Agreement for the company’s first Aurora reactor at Idaho National Laboratory under the DOE Reactor Pilot Program, and the Nuclear Regulatory Commission issued a materials license to Oklo’s subsidiary Atomic Alchemy to handle isotope materials at its Idaho Radiochemistry Laboratory. Those steps move the Aurora project closer to on-site work and permit Atomic Alchemy to receive, process and distribute isotope material from the Idaho facility.
Market behavior tracked the news intraday: shares popped about 10% in early Tuesday morning trade, then pulled back but remained in positive territory at roughly 3% higher as of 1: 30 p. m. ET Tuesday. The DOE agreement was framed as the next phase of execution for the Aurora reactor, and the NRC license enables initial commercial activity tied to isotope recovery and processing.
Immediate Reactions
Jacob DeWitte, CEO and co-founder of Oklo, said, “Demand for critical isotopes is rising, but U. S. supply remains limited. This work helps create a more resilient and dependable domestic supply chain of isotopes and supports the transition from early operations to durable, commercial isotope production in the United States. “
Institutional commentary followed the announcements: Texas Capital Securities reiterated its buy rating and maintained a $138 price target for the stock. The materials license authorizes Atomic Alchemy to receive and process specific isotope materials at the Idaho Radiochemistry Laboratory and to conduct distribution activities consistent with NRC requirements.
Quick Context
Oklo is developing fast-fission Aurora power plants and has positioned an isotope business through Atomic Alchemy to recycle used fuel into high-value radioisotopes. Operating experience at the Idaho Radiochemistry Laboratory is intended to inform procedures for a planned multi-reactor isotope foundry that Oklo envisions using non-power Versatile Isotope Production Reactor systems.
What’s Next
All eyes turn to Oklo’s earnings release after market close on March 17 at 5: 00 p. m. ET and the subsequent conference call for management detail. Investors will be watching for updates on timelines for initial isotope processing and the deployment schedule for the first Aurora reactor, plus clarity on cash position and plans to secure capital for reactor and recycling buildout — factors that will shape the near-term trajectory of oklo stock as the story moves from approval to execution.



